369 related articles for article (PubMed ID: 34389865)
21. Dedifferentiation rescues senescence of progeria cells but only while pluripotent.
Niedernhofer LJ; Glorioso JC; Robbins PD
Stem Cell Res Ther; 2011 Jun; 2(3):28. PubMed ID: 21639955
[TBL] [Abstract][Full Text] [Related]
22. Metformin alleviates ageing cellular phenotypes in Hutchinson-Gilford progeria syndrome dermal fibroblasts.
Park SK; Shin OS
Exp Dermatol; 2017 Oct; 26(10):889-895. PubMed ID: 28192606
[TBL] [Abstract][Full Text] [Related]
23. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
Brassard JA; Fekete N; Garnier A; Hoesli CA
Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
[TBL] [Abstract][Full Text] [Related]
24. Are There Common Mechanisms Between the Hutchinson-Gilford Progeria Syndrome and Natural Aging?
Ashapkin VV; Kutueva LI; Kurchashova SY; Kireev II
Front Genet; 2019; 10():455. PubMed ID: 31156709
[TBL] [Abstract][Full Text] [Related]
25. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach.
Rajeev M; Ratan C; Krishnan K; Vijayan M
Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y Enhances Progerin Clearance and Ameliorates the Senescent Phenotype of Human Hutchinson-Gilford Progeria Syndrome Cells.
Aveleira CA; Ferreira-Marques M; Cortes L; Valero J; Pereira D; Pereira de Almeida L; Cavadas C
J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1073-1078. PubMed ID: 32012215
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford Progeria Syndrome.
Aguado J; Sola-Carvajal A; Cancila V; Revêchon G; Ong PF; Jones-Weinert CW; Wallén Arzt E; Lattanzi G; Dreesen O; Tripodo C; Rossiello F; Eriksson M; d'Adda di Fagagna F
Nat Commun; 2019 Nov; 10(1):4990. PubMed ID: 31740672
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
[TBL] [Abstract][Full Text] [Related]
29. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.
Benedicto I; Dorado B; Andrés V
Cells; 2021 May; 10(5):. PubMed ID: 34064612
[TBL] [Abstract][Full Text] [Related]
30. Hutchinson-Gilford Progeria Syndrome: Cellular Mechanisms and Therapeutic Perspectives.
Cisneros B; García-Aguirre I; De Ita M; Arrieta-Cruz I; Rosas-Vargas H
Arch Med Res; 2023 Jul; 54(5):102837. PubMed ID: 37390702
[TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetic insights into the ageing syndrome Hutchinson-Gilford Progeria (HGPS).
Corso C; Parry EM; Faragher RG; Seager A; Green MH; Parry JM
Cytogenet Genome Res; 2005; 111(1):27-33. PubMed ID: 16093717
[TBL] [Abstract][Full Text] [Related]
32. iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome.
Atchison L; Abutaleb NO; Snyder-Mounts E; Gete Y; Ladha A; Ribar T; Cao K; Truskey GA
Stem Cell Reports; 2020 Feb; 14(2):325-337. PubMed ID: 32032552
[TBL] [Abstract][Full Text] [Related]
33. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
[TBL] [Abstract][Full Text] [Related]
34. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
36. Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome.
Mao X; Xiong ZM; Xue H; Brown MA; Gete YG; Yu R; Sun L; Cao K
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628310
[TBL] [Abstract][Full Text] [Related]
37. Anti-hsa-miR-59 alleviates premature senescence associated with Hutchinson-Gilford progeria syndrome in mice.
Hu Q; Zhang N; Sui T; Li G; Wang Z; Liu M; Zhu X; Huang B; Lu J; Li Z; Zhang Y
EMBO J; 2023 Jan; 42(1):e110937. PubMed ID: 36382717
[TBL] [Abstract][Full Text] [Related]
38. Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome.
Cabral WA; Tavarez UL; Beeram I; Yeritsyan D; Boku YD; Eckhaus MA; Nazarian A; Erdos MR; Collins FS
Aging Cell; 2021 Sep; 20(9):e13457. PubMed ID: 34453483
[TBL] [Abstract][Full Text] [Related]
39. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.
Zhang J; Lian Q; Zhu G; Zhou F; Sui L; Tan C; Mutalif RA; Navasankari R; Zhang Y; Tse HF; Stewart CL; Colman A
Cell Stem Cell; 2011 Jan; 8(1):31-45. PubMed ID: 21185252
[TBL] [Abstract][Full Text] [Related]
40. Mitophagy defect mediates the aging-associated hallmarks in Hutchinson-Gilford progeria syndrome.
Sun Y; Xu L; Li Y; Jia S; Wang G; Cen X; Xu Y; Cao Z; Wang J; Shen N; Hu L; Zhang J; Mao J; Xia H; Liu Z; Fu X
Aging Cell; 2024 Jun; 23(6):e14143. PubMed ID: 38482753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
